Header Logo

Connection

Fatima Laher to Acyltransferases

Back to Details
This is a "connection" page, showing publications Fatima Laher has written about Acyltransferases.
Fatima Laher
Connection Strength
0,032
Acyltransferases
  1. A double-blind, randomised, placebo-controlled, dose-finding trial of the novel tuberculosis vaccine AERAS-402, an adenovirus-vectored fusion protein, in healthy, BCG-vaccinated infants. Vaccine. 2015 Jun 09; 33(25):2944-54.
    View in: PubMed
    Score: 0,032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.